Oncology Drugs to Watch

Top takeaways from ASCO 2023

As part of our Drugs to Watch™ program, Clarivate experts use proprietary data sources, landscape and event monitoring, and deep market knowledge to identify key drug developments expected to have a significant impact on patients and markets.

This report explores treatment breakthroughs highlighted at ASCO 2023, the biggest oncology event of the year, and provides an analysis on how they will reshape the landscape, along with an analysis of some standout oncology therapeutics in the rapidly expanding Mainland China marketplace.

At Clarivate, our vision is to improve the way the world creates, protects, and advances innovation. We can better understand the changing oncology landscape by leveraging our deep market expertise, data, and insights solutions. Furthermore, our experts leverage a variety of proprietary data sources to advise clients on key trends and developments in the oncology space.

Download the report to access detailed insights.